Rigel Pharmaceuticals, Inc(NASDAQ:RIGL) 
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocy...
Website: http://www.rigel.com
Founded: 1996
Full Time Employees: 163
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 16.57
H 17.49
L 16.57
C 17.24
V 232,152
10EMA 17.24
20EMA 17.24
60EMA 17.24
120EMA 17.24
250EMA 17.24